Olistavir lmpurity 198 CAS CATO-C4X-1720198
| CAS No. | CATO-C4X-1720198 |
| Molecular Formula | C13H20N2O5 |
| Molecular Weight | N/A |
| Category | Pharmacopoeial Impurity Standards / EP Impurities |
| Availability | In Stock |
Chemical Structure
Description
The occurrence of Olistavir lmpurity 198 is closely related to a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage, chlorine substitution in its molecular formula, which determines its behaviour during synthesis, purification, or degradation.
As a process- or degradation-related impurity, Olistavir lmpurity 198 (CAS CATO-C4X-1720198, C13H20N2O5HCl) is essential for impurity profiling, related-substances testing, and forced-degradation studies in pharmaceutical development.
Olistavir lmpurity 198 (C13H20N2O5HCl) contains a nitrogen-containing heterocyclic scaffold, an amide group, a hydroxyl group, an ether linkage, chlorine substitution. It is notably hygroscopic, halogen substitution raises its density and boiling point, the carboxyl group imparts weak acidity; these physicochemical properties determine the optimal preparation and storage of its standard solutions. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).
This reference standard supports related-substances testing and method development in line with ICH Q3A/Q3B guidance on impurity control, and is suitable for system suitability testing and forced-degradation studies.
CATO manufactures Olistavir lmpurity 198 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.
Physical & Chemical Properties
| Molecular Formula | C13H20N2O5 HCl |
| Molecular Weight | 320.77 g/mol |
| Appearance | Off-white to pale yellow crystalline powder. (slight halide-like odor) |
| Purity | 97%+ |
| Storage | Store at 2-8°C, protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 4.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| Halogen Content | Cl-containing |
| Nitrogen Atoms | 2 |
Related Olistavir Standards
Recommended Standards
- Tepotinib impurity 27 (CAS CATO-C4X-337427)
- Eltrombopag Impurity 49 (CAS 67666-03-9)
- Oxybuprocaine Impurity 1 (CAS CATO-C4X-28331)
- Methyl 5-hexenoate (CAS 2396-80-7)
- 2-(1H-imidazol-1-yl)ethane-1-sulfonyl chloride hydrochloride (CAS 1955557-93-3)
- 3-Chloro-5-cyclopropoxy-4-fluoropyridine (CAS 1243445-95-5)
- (2Z)-3-(4-Chlorophenyl)-2-(4-iodophenyl)-acrylic acid (CAS 3163-82-4)
- 2-(1H-Pyrazol-1-yl)-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyrimidine (CAS 1449009-97-5)
- Plerixafor Impurity 12 (CAS CATO-C4X-113312)
- Semaglutide impurity 289 (CAS CATO-C4X-2226289)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com